Optimising immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost-minimisation analysis

Author： Odeyemi Isaac A. O.   Danø Anne M.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.1, 2009-01, pp. : 239-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : 559-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : 559-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on‐demand with bypass treatment

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 310-319

John Wiley & Sons Inc

Access to resources Recommend Favorite

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e369-e374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : e369-e374

John Wiley & Sons Inc

Access to resources Recommend Favorite